186 related articles for article (PubMed ID: 10490828)
41. Induction of HLA class II genes by IFN-gamma is transcriptional and requires a trans-acting protein.
Amaldi I; Reith W; Berte C; Mach B
J Immunol; 1989 Feb; 142(3):999-1004. PubMed ID: 2492334
[TBL] [Abstract][Full Text] [Related]
42. Regulation of class II MHC gene expression by interferons: insights into the mechanism of action of interferon (review).
Giacomini P; Fisher PB; Duigou GJ; Gambari R; Natali PG
Anticancer Res; 1988; 8(6):1153-61. PubMed ID: 2464333
[TBL] [Abstract][Full Text] [Related]
43. Catecholamines stimulate MHC class I, class II, and invariant chain gene expression in brain endothelium through different mechanisms.
Bourdoulous S; Durieu-Trautmann O; Strosberg AD; Couraud PO
J Immunol; 1993 Feb; 150(4):1486-95. PubMed ID: 8432989
[TBL] [Abstract][Full Text] [Related]
44. Interferon-gamma, mitomycin C, and cycloheximide as regulatory agents of MHC class II-associated invariant chain expression.
Rahmsdorf HJ; Harth N; Eades AM; Litfin M; Steinmetz M; Forni L; Herrlich P
J Immunol; 1986 Mar; 136(6):2293-9. PubMed ID: 3081641
[TBL] [Abstract][Full Text] [Related]
45. Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene.
Peijnenburg A; Van den Berg R; Van Eggermond MJ; Sanal O; Vossen JM; Lennon AM; Alcaïde-Loridan C; Van den Elsen PJ
Immunogenetics; 2000 Jan; 51(1):42-9. PubMed ID: 10663561
[TBL] [Abstract][Full Text] [Related]
46. Downregulating immunogenicity of Schwann cells via inhibiting a potential target of class II transactivator (CIITA) gene.
Yang Y; Dai W; Chen Z; Yan Z; Yao Z; Zhang C
Biosci Trends; 2013 Feb; 7(1):50-5. PubMed ID: 23524893
[TBL] [Abstract][Full Text] [Related]
47. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
[TBL] [Abstract][Full Text] [Related]
48. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
Wang Y; Xu M; Che M; Von Hofe E; Abbas A; Kallinteris NL; Lu X; Liss ZJ; Forman JD; Hillman GG
Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
[TBL] [Abstract][Full Text] [Related]
49. The RAG cell line defines a new complementation group of MHC class II deficiency.
Lennon A; Ottone C; Peijnenburg A; Hamon-Benais C; Colland F; Gobin S; van den Elsen P; Fellous M; Bono R; Alcaïde-Loridan C
Immunogenetics; 1996; 43(6):352-9. PubMed ID: 8606055
[TBL] [Abstract][Full Text] [Related]
50. The invariant chain gene intronic enhancer shows homology to class II promoter elements.
Moore BB; Cao ZA; McRae TL; Woo CH; Conley S; Jones PP
J Immunol; 1998 Aug; 161(4):1844-52. PubMed ID: 9712052
[TBL] [Abstract][Full Text] [Related]
51. Delayed allograft rejection by the suppression of class II transactivator.
Kim TW; Choi YM; Seo JN; Kim JH; Suh YH; Chung DH; Jung KC; Oh KI
Exp Mol Med; 2006 Jun; 38(3):210-6. PubMed ID: 16819279
[TBL] [Abstract][Full Text] [Related]
52. Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.
Kielar ML; Sicher SC; Penfield JG; Jeyarajah DR; Lu CY
Inflammation; 2000 Oct; 24(5):431-45. PubMed ID: 10921507
[TBL] [Abstract][Full Text] [Related]
53. In vivo class II transactivator expression in mice is induced by a non-interferon-gamma mechanism in response to local injury.
Sims TN; Goes NB; Ramassar V; Urmson J; Halloran PF
Transplantation; 1997 Dec; 64(12):1657-64. PubMed ID: 9422398
[TBL] [Abstract][Full Text] [Related]
54. H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines.
Walter W; Scheuer C; Lingnau K; Reichert TE; Schmitt E; Loos M; Maeurer MJ
Immunogenetics; 2000 Aug; 51(10):794-804. PubMed ID: 10970094
[TBL] [Abstract][Full Text] [Related]
55. Failure of MHC class II expression in neonatal alveolar macrophages: potential role of class II transactivator.
Lee PT; Holt PG; McWilliam AS
Eur J Immunol; 2001 Aug; 31(8):2347-56. PubMed ID: 11477547
[TBL] [Abstract][Full Text] [Related]
56. Loss of MHC class II inducibility in hyperplastic tissue in Rb-defective mice.
Eason DD; Coppola D; Livingston S; Shepherd AT; Blanck G
Cancer Lett; 2001 Oct; 171(2):209-14. PubMed ID: 11520605
[TBL] [Abstract][Full Text] [Related]
57. Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells.
Dellabona P; Latron F; Maffei A; Scarpellino L; Accolla RS
J Immunol; 1989 Apr; 142(8):2902-10. PubMed ID: 2495328
[TBL] [Abstract][Full Text] [Related]
58. Transcription of the murine class II Eb gene is regulated primarily at the level of transcriptional initiation.
Egan RM; Brockman JA; Omer KW; Woodward JG
Cell Immunol; 1994 Jul; 156(2):537-43. PubMed ID: 8025961
[TBL] [Abstract][Full Text] [Related]
59. Evidence for the in vivo role of class II transactivator in basal and IFN-gamma induced class II expression in mouse tissue.
Ramassar V; Goes N; Hobart M; Halloran PF
Transplantation; 1996 Dec; 62(12):1901-7. PubMed ID: 8990384
[TBL] [Abstract][Full Text] [Related]
60. Quantitative control of MHC class II expression by the transactivator CIITA.
Otten LA; Steimle V; Bontron S; Mach B
Eur J Immunol; 1998 Feb; 28(2):473-8. PubMed ID: 9521055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
